Literature DB >> 23727039

What is an "eosinophilic phenotype" of asthma?

Parameswaran Nair.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23727039     DOI： 10.1016/j.jaci.2013.05.007

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  17 in total

Review 1.  Update on reslizumab for eosinophilic asthma.

Authors:  Juan Carlos Cardet; Elliot Israel
Journal:  Expert Opin Biol Ther       Date:  2015       Impact factor: 4.388

2.  Periostin - A Novel Systemic Biomarker for Eosinophilic Airway Inflammation: A Case Control Study.

Authors:  Viswanathan Emprm; M G Rajanandh; A D Nageswari
Journal:  J Clin Diagn Res       Date:  2016-02-01

Review 3.  Interleukin-5 Antagonists Usher in a New Generation of Asthma Therapy.

Authors:  Matthew P Giannetti; Juan C Cardet
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

Review 4.  Toward precision medicine and health: Opportunities and challenges in allergic diseases.

Authors:  Stephen Joseph Galli
Journal:  J Allergy Clin Immunol       Date:  2016-05       Impact factor: 10.793

5.  Advances in pediatric asthma in 2013: coordinating asthma care.

Authors:  Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2014-03       Impact factor: 10.793

6.  Generation of IL10 and TGFB1 coexpressed mice displaying resistance to ovalbumin-induced asthma.

Authors:  Fei Xu; Xiuhua Kang; Liang Chen; Chuanhui Chen; Gen Hu; Wei Bai; Wei Zhang
Journal:  Transgenic Res       Date:  2016-10-01       Impact factor: 2.788

Review 7.  Biological therapies for eosinophilic asthma.

Authors:  Shiven S Patel; Thomas B Casale; Juan Carlos Cardet
Journal:  Expert Opin Biol Ther       Date:  2018-07-04       Impact factor: 4.388

Review 8.  Anti-IL5 therapy for asthma and beyond.

Authors:  Manali Mukherjee; Roma Sehmi; Parameswaran Nair
Journal:  World Allergy Organ J       Date:  2014-12-04       Impact factor: 4.084

9.  Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma.

Authors:  Bart Hilvering; Timothy S C Hinks; Linda Stöger; Emanuele Marchi; Maryam Salimi; Rahul Shrimanker; Wei Liu; Wentao Chen; Jian Luo; Simei Go; Timothy Powell; Jennifer Cane; Samantha Thulborn; Ayako Kurioka; Tianqi Leng; Jamie Matthews; Clare Connolly; Catherine Borg; Mona Bafadhel; Christian B Willberg; Adaikalavan Ramasamy; Ratko Djukanović; Graham Ogg; Ian D Pavord; Paul Klenerman; Luzheng Xue
Journal:  Mucosal Immunol       Date:  2018-06-15       Impact factor: 7.313

Review 10.  Immune monitoring for precision medicine in allergy and asthma.

Authors:  Scott Dexter Boyd; Ramona Amy Hoh; Kari Christine Nadeau; Stephen Joseph Galli
Journal:  Curr Opin Immunol       Date:  2017-09-07       Impact factor: 7.486
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.